BloodScan Biotech Inc.
- Academic, tech transfer
- Diagnostics
- Medical device or technology
BloodScan Biotech is a University of Michigan spin-out advancing next-generation liquid biopsy technology through its flagship platform, Labyrinth One—a fully automated system for high-purity, label-free, and viable CTC isolation in under 15 minutes. We bridge Taiwan’s hardware manufacturing strengths with U.S. academic excellence to accelerate innovation and impact in cancer care.